Company
Design Therapeutics Inc (NASDAQ: DSGN) Up Almost 27.59% In One Month, Long Term Looking Good
Design Therapeutics Inc (NASDAQ:DSGN)’s traded shares stood at 0.39 million during the last session, with the company’s beta value hitting 1.80. At the close of
